Day 2: Valiant Laboratories IPO GMP Subscription Allotment Today

HP Jinjholiya
Valiant Lab IPO GMP Date, Price, Allotment, Subscription, Details

Valiant Laboratories is set to open its IPO on 27 September 2023 and will be listed on the stock exchange on 9th October 2023. Many are closely watching the Valiant Laboratories IPO GMP to gauge investor sentiment.

Today 10th day of the Valiant Laboratories grey market premium (GMP).  You can pre-apply for the Valiant Laboratories IPO on Upstox. which means the pre-apply open date, usually begins a day before the IPO opens for the subscription.

Valiant Laboratories IPO GMP Today


On 19 September 2023, the GMP remained unchanged with no movement, and the estimated listing price was â‚ą140, showing no percentage change.

The same trend continued for the next few days. On 20 September 2023, 21 September 2023, 22 September 2023, 23 September 2023, 24 September 2023, and 25 September 2023, the GMP showed no change, maintaining its position at â‚ą0. The estimated listing price on these dates remained consistent at â‚ą140, with no percentage change.

However, on 26 September 2023, there was a slight uptick. The GMP for the IPO was â‚ą10, marking an upward movement. The estimated listing price for this day was â‚ą150, reflecting a 7.14% increase.

The positive trend continued on 27 September 2023, with the GMP rising to â‚ą17. The Sub2 Sauda Rate for this day was 1400/19600. Consequently, the estimated listing price increased to â‚ą157, marking a 12.14% rise.

As of the latest update on 28 September 2023, the GMP for Valiant Laboratories’ IPO stands at â‚ą17, with today’s movement indicating an upward trend. The Sub2 Sauda Rate is noted at 1400/19600. The estimated listing price, as of this date, is â‚ą157, showing a 12.14% increase.

Valiant Laboratories IPO Subscription


On the first day of bidding, 27 September 2023, the Qualified Institutional Buyers (QIB) segment did not show any subscription, standing at 0.00x. The Non-Institutional Investors (NII) segment was subscribed at 0.10x, while the Small Non-Institutional Investors (SNII) segment, which includes bids below â‚ą10L, was subscribed at 0.15x.

The Big Non-Institutional Investors (BNII) segment, accounting for bids above â‚ą10L, stood at 0.08x. Retail Individual Investors (RII) showed a relatively higher interest with a subscription rate of 0.62x. Overall, the total subscription for the day was 0.33x against the total shares offered, which amounts to 76,23,030.

The momentum picked up on the second day, 28 September 2023. The QIB segment saw a slight increase in interest, with a subscription rate of 0.05x. The NII segment rose to 0.23x, and the SNII segment witnessed a significant jump to 0.47x.

The BNII segment was subscribed at 0.12x. The RII segment continued its upward trajectory, reaching a subscription rate of 1.19x. The total subscription for the day doubled from the previous day, standing at 0.66x.

To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us. Check out Today’s Share Market Open or Closed.

Google NewsFacebook
TelegramYoutube

it’s important to note that GMP is not an official measure and often varies. It provides an early indicator of potential demand but does not guarantee the actual listing price. The GMP prices shown here are only news related to the grey market. We do not trade/deal in the grey market or subject to rates (sub2), nor do we recommend trading in the grey market

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Sharedhan. We advise investors to check with certified experts before making any investment decisions.

Share this Article
Follow:
Hey Investor, My name is HP Jinjholiya, a professional blogger with over 5 years of personal experience in the share market & stock investments. The insights and information shared in this article are grounded in expert analysis and research from industry leaders, translating complex expert opinions into accessible insights for a broader audience.
Leave a comment